Cargando…

TRIANGLE operation for borderline resectable pancreatic cancer in total pancreatectomy

BACKGROUND: Pancreatic cancer is a highly aggressive cancer featured by early metastasis and multiple chemoresistance. Surgical resection remains the only way for the radical cure of pancreatic cancer. The aim of this study was to assess the safety, feasibility and oncological effect of the Heidelbe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhai, Shuyu, Huo, Zhen, Wang, Yue, Qian, Hao, Zhao, Shulin, Shi, Yusheng, Weng, Yuanchi, Deng, Xiaxing, Shen, Baiyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798168/ https://www.ncbi.nlm.nih.gov/pubmed/35116994 http://dx.doi.org/10.21037/tcr.2019.09.50

Ejemplares similares

Robotic-assisted versus open distal pancreatectomy for benign and low-grade malignant pancreatic tumors: a propensity score-matched study
por: Weng, Yuanchi, et al.
Publicado: (2020)

Comparison of Radical Antegrade Modular Pancreatosplenectomy with Standard Retrograde Pancreatosplenectomy for Left-Sided Pancreatic Cancer: A Meta-Analysis and Experience of a Single Center
por: Huo, Zhen, et al.
Publicado: (2019)

PRPF40A as a potential diagnostic and prognostic marker is upregulated in pancreatic cancer tissues and cell lines: an integrated bioinformatics data analysis
por: Huo, Zhen, et al.
Publicado: (2019)

Identification of EMT-related alternative splicing event of TMC7 to promote invasion and migration of pancreatic cancer
por: Weng, Yuanchi, et al.
Publicado: (2023)

Worth it or not? Primary tumor resection for stage IV pancreatic cancer patients: A SEER‐based analysis of 15,836 cases
por: Fu, Ningzhen, et al.
Publicado: (2021)

Oncological outcomes of robotic-assisted versus open pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score-matched analysis
por: Weng, Yuanchi, et al.
Publicado: (2020)

A new enhanced recovery after surgery pathway for left-sided pancreatic cancer patients after distal pancreatectomy
por: Wang, Yue, et al.
Publicado: (2019)

Predicting Selection Preference of Robotic Pancreaticoduodenectomy (RPD) in a Chinese Single Center Population: Development and Assessment of a New Predictive Nomogram
por: Huo, Zhen, et al.
Publicado: (2019)

Construction and integrated analysis of a lncRNA-associated competing endogenous RNA network reveal functional lncRNAs in pancreatic cancer
por: Liu, Yuanbin, et al.
Publicado: (2020)

Does Pre-operative Biliary Drainage Influence Long-Term Survival in Patients With Obstructive Jaundice With Resectable Pancreatic Head Cancer?
por: Shen, Ziyun, et al.
Publicado: (2020)

Short-term Outcomes After Robot-Assisted vs Open Pancreaticoduodenectomy After the Learning Curve
por: Shi, Yusheng, et al.
Publicado: (2020)

miR-934 as a Prognostic Marker Facilitates Cell Proliferation and Migration of Pancreatic Tumor by Targeting PROX1
por: Jin, Yangbing, et al.
Publicado: (2020)

Has the pancreatic fistula already occurred in the operation? An intraoperative predictive factor of clinical relevant-postoperative pancreatic fistula after the distal pancreatectomy()()
por: Wang, Weishen, et al.
Publicado: (2019)

Laparoscopic pancreatectomies for borderline tumors with major venous resections
por: Borys, Maciej, et al.
Publicado: (2022)

Robot-Assisted Middle Pancreatectomy for Elderly Patients: Our Initial Experience
por: Zhang, Tian, et al.
Publicado: (2015)

Prognostic Analysis and Influencing Serum Biomarkers of Patients With Resectable Pancreatic Adenosquamous Cancer
por: Shi, Yusheng, et al.
Publicado: (2021)

Prognostic Value of Neoadjuvant Chemotherapy in Patients with Borderline Resectable Pancreatic Carcinoma Followed by Pancreatectomy with Portal Vein Resection and Reconstruction with Venous Allograft
por: Huang, Jin-Can, et al.
Publicado: (2022)

Minimally invasive distal pancreatectomy for PNETs: laparoscopic or robotic approach?
por: Zhang, Jiaqiang, et al.
Publicado: (2017)

Systematic Review and Meta-Analysis of Pancreatic Amylase Value on Postoperative Day 1 After Pancreatic Resection to Predict Postoperative Pancreatic Fistula
por: Lu, Xiongxiong, et al.
Publicado: (2016)

Intraoperative Positive Pancreatic Parenchymal Resection Margin: Is It a True Indication of Completion Total Pancreatectomy after Partial Pancreatectomy for Pancreatic Ductal Adenocarcinoma?
por: Jung, Ji-Hye, et al.
Publicado: (2022)

A Nomogram for Individual Prediction of Poor Prognosis After Radical Surgery in Patients with Primary Pancreatic Duct Adenocarcinoma
por: Zhai, Shuyu, et al.
Publicado: (2020)

The impact of Omicron pandemic and COVID‐19 vaccination on the pancreatic adenocarcinoma patients
por: Fu, Ningzhen, et al.
Publicado: (2022)

CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
por: Maggino, Laura, et al.
Publicado: (2022)

Hypoxia-induced exosomal circPDK1 promotes pancreatic cancer glycolysis via c-myc activation by modulating miR-628-3p/BPTF axis and degrading BIN1
por: Lin, Jiewei, et al.
Publicado: (2022)

Total pancreatectomy and pancreatic fistula: friend or foe?
por: Salvia, Roberto, et al.
Publicado: (2021)

Risk factors for and prognostic values of postoperative acute kidney injury after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: A retrospective, propensity score‐matched cohort study of 1312 patients
por: Ji, Yuchen, et al.
Publicado: (2022)

Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection
por: Chen, Haoda, et al.
Publicado: (2021)

Positive feedback between lncRNA FLVCR1-AS1 and KLF10 may inhibit pancreatic cancer progression via the PTEN/AKT pathway
por: Lin, Jiewei, et al.
Publicado: (2021)

Mesenteric-Portal Vein Resection during Pancreatectomy for Pancreatic Cancer
por: Beltrame, Valentina, et al.
Publicado: (2015)

Radical Resection for Locally Advanced Pancreatic Cancers in the Era of New Neoadjuvant Therapy—Arterial Resection, Arterial Divestment and Total Pancreatectomy
por: Inoue, Yosuke, et al.
Publicado: (2021)

Postoperative hyperprogression disease of pancreatic ductal adenocarcinoma after curative resection: a retrospective cohort study
por: Zou, Siyi, et al.
Publicado: (2022)

INPP4B As A Prognostic And Diagnostic Marker Regulates Cell Growth Of Pancreatic Cancer Via Activating AKT
por: Zhai, Shuyu, et al.
Publicado: (2019)

Total Pancreatectomy with Islet Autologous Transplantation: The Cure for Chronic Pancreatitis?
por: Kesseli, Samuel J, et al.
Publicado: (2015)

Borderline resectable pancreatic cancer: Certainties and controversies
por: Nappo, Gennaro, et al.
Publicado: (2021)

Real‐world implications of nonbiological factors with staging, clinical management, and prognostic prediction in pancreatic ductal adenocarcinoma
por: Wang, Chao, et al.
Publicado: (2022)

Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer
por: Janssen, Quisette P., et al.
Publicado: (2020)

Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer
por: Massani, Marco, et al.
Publicado: (2023)

Short-Course or Total Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer - Current Status and Future Perspectives
por: Labori, Knut Jørgen
Publicado: (2022)

Vascular Resection in Pancreatectomy—Is It Safe and Useful for Patients with Advanced Pancreatic Cancer?
por: Jabłońska, Beata, et al.
Publicado: (2022)

A Prognostic Impact of Splenectomy in Laparoscopic Distal Pancreatectomy on Benign/Borderline Pancreatic Tumors: A Change of the Era
por: Hong, Seung Soo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4p86shgh25vahiiaugie75jtsq